Yellow Fever Research Today is a free monthly online journal that collates and summarizes the latest research about Yellow Fever, including details on immunization, vaccines, symptoms, transmission. | ||||||||
|
Yellow fever-associated viscerotropic disease in Barcelona, Spain.Muñoz J, Vilella A, Domingo C, Nicolas JM, de Ory F, Corachan M, Tenorio A, Gascon J Barcelona Centre for International Health Research (CRESIB), Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. jmunozg@clinic.ub.es Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination. Published 22 May 2008 in J Travel Med, 15(3): 202-5.
© 2005-2008 Yellow Fever Research Today. All Rights Reserved. |
| ||||||